And when World War II erupted in earnest in September 1939, the Stuka spearheaded Germany’s Blitzkrieg into Poland, France, ...

KAB bombs, a combination of old FAB bombs and UMPK modules, are a crucial weapon type enabling Russians to occupy territory in Ukraine. Surprisingly, their production would not be possible without ...

Explosions rang out and air raid sirens sounded over the Ukrainian capital Kyiv on Tuesday night after Vladimir Putin ordered ...

Long Beach-based Rocket Lab USA Inc. announced a deal to acquire Mynaric, a German manufacturer of satellite components, in a deal that could be valued at up to $150 million. The initial purchase ...

U.S. aerospace company Rocket Lab said it plans to acquire Mynaric, a German company responsible for manufacturing communication equipment for satellite constellations. In a statement Tuesday ...

The duo launched on a SpaceX Falcon 9 rocket at 11:10 p.m. EST (0310 March 12 GMT). There was a glimmer in the air tonight at Vandenberg Space Force Base in California, and it wasn't only because ...

Malaysia has tightened security along its border with Thailand following a bomb blast in the neighbouring nation. Inspector General Razarudin Husain said on Sunday that the police were closely ...

An official report on the state of the German military painted a grim picture on Tuesday, with a whopping 28% of positions among the lower enlisted ranks unfilled as of the end of 2024.

GameSpot may get a commission from retail offers. Developer Psyonix has announced a futuristic theme for Rocket League Season 18, with this new season kicking off on March 14. The season brings a ...

Rocket Cos. is pushing deeper into the property market with a deal to buy Redfin Corp. that values the real estate listing site at $1.75 billion. The Detroit-based financial technology group will ...

The payload is the next batch of SpaceX's Starlink internet satellites. As it flies into the night sky, the rocket will travel southeast from the launch pad. When is the next launch? Is there a ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that the Kyowa Kirin-partnered rocatinlimab improves outcomes in atopic ...